Sputnik V vaccine 83 per cent effective against Delta variant of COVID-19, says Russian health ministry

"The Russian Ministry of Health has also published data on Sputnik V`s efficacy against the Delta variant. The vaccine is 83.1 per cent effective and shows 6x reduction of infection risk," RDIF said in a statement. 

New Delhi: As the world combats the deadly Delta COVID-19 variant, Russian Direct Investment Fund (RDIF) on Wednesday (August 11) said Russia's Sputnik V vaccine is around 83 per cent effective against the Delta variant, ANI reported.  Citing data gathered by the Russian health ministry, the RDIF said in a statement, "The data confirms that Sputnik V remains protective against newly detected variants and retains one of the best safety and efficacy parameters. The Russian Ministry of Health has also published data on Sputnik V`s efficacy against the Delta variant. The vaccine is 83.1 per cent effective and shows 6x reduction of infection risk. Sputnik V is also 94.4 per cent effective against hospitalizations with 18x reduction in hospitalisation risk.”  The statement added that Sputnik V, a two-shot vaccine, showed 97.6% efficacy based on the analysis of data from 3.8 million vaccinated people in Russia. “The results obtained over the course of mass vaccination were even better than those seen during clinical trials (91.6% efficacy),” it added.